Detection of androgen receptor (AR) and AR-V7 in small cell prostate carcinoma: Diagnostic and therapeutic implications

OBJECTIVE: Small cell prostate carcinoma (SCPC) is a rare and highly malignant subtype of prostate cancer. SCPC frequently lacks androgen receptor (AR) and prostate-specific antigen (PSA) expression, and often responds poorly to androgen deprivation therapy (ADT). AR splice variant-7 (AR-V7) is a tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Pei, Zhu, Yezi, Cheng, Liang, Luo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Second Military Medical University 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363596/
https://www.ncbi.nlm.nih.gov/pubmed/30775254
http://dx.doi.org/10.1016/j.ajur.2018.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363596/
https://www.ncbi.nlm.nih.gov/pubmed/30775254
http://dx.doi.org/10.1016/j.ajur.2018.09.003

Ejemplares similares